Albany Molecular Research, Inc. Announces Promotions of Key Staff.Business Editors ALBANY, N.Y.--(BUSINESS WIRE)--April 29, 2002 Albany Molecular Research, Inc. (Nasdaq: AMRI AMRI Albany Molecular Research (stock symbol) AMRI Advanced Magnetic Research Institute (Mocksville, NC) AMRI Advanced Materials Research Institute AMRI Adult Movie Review Index ) Chairman and Chief Executive Officer Thomas E. D'Ambra, Ph.D. today announced a number of employee promotions, including the promotions of several key scientific managers. Management-level promotions include the following: Bruce F. Molino, Ph.D. was promoted to the position of senior director, medicinal chemistry Medicinal or pharmaceutical chemistry is a scientific discipline at the intersection of chemistry and pharmacology involved with designing, synthesizing and developing pharmaceutical drugs. . In this leadership role, Dr. Molino is responsible for managing drug discovery projects in AMRI's largest department. He joined AMRI in 1998, bringing to the company extensive experience in the pharmaceutical industry. He began his career in 1984 at Rhone-Poulenc Rorer, Inc., where he was promoted through the ranks to director of thrombosis, and led a group of scientists in the discovery of the clinical development candidate Klerval(TM), a novel anti-platelet agent for the prevention of arterial thrombosis. In 1994, he moved to Rhone-Poulenc Rorer in England and served as director of respiratory and inflammation chemistry for two years. Dr. Molino then took up a new post in medicinal chemistry at Helios Pharmaceuticals. He obtained his Ph.D. in organic chemistry from the University of Maryland University of Maryland can refer to:
J. Gregory Reid, Ph.D. has been promoted to senior director, process research and development. Dr. Reid leads the company's Syracuse Research Center, which conducts both small-scale and kilo-scale custom organic synthesis Organic synthesis is the construction of organic molecules via chemical processes. Organic molecules can often contain a higher level of complexity compared to purely inorganic compounds, so the synthesis of organic compounds has developed into one of the most important aspects of and process R&D for AMRI customers. Dr. Reid is a seasoned pharmaceutical industry scientist with wide-ranging expertise in chemical development and custom synthesis. Prior to joining AMRI, Dr. Reid co-founded American Advanced Organics (AAO AAO American Association of Orthodontists; American Academy of Ophthalmology; American Academy of Otolaryngology; American Academy of Osteopathy. AAO ), which AMRI acquired in February 2000. Dr. Reid also worked as a research scientist and manager in the area of chemical process R&D at Upjohn (now Pharmacia) and Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were . He earned his Ph.D. in chemistry from the University of Wisconsin and conducted postdoctoral studies at Harvard University Harvard University, mainly at Cambridge, Mass., including Harvard College, the oldest American college. Harvard College Harvard College, originally for men, was founded in 1636 with a grant from the General Court of the Massachusetts Bay Colony. with Nobel Laureate Noun 1. Nobel Laureate - winner of a Nobel prize Nobelist laureate - someone honored for great achievements; figuratively someone crowned with a laurel wreath E. J. Corey. Allen H. Salerno, Ph.D. was promoted to the position of director, analytical chemistry analytical chemistry: see under chemistry. . Dr. Salerno leads AMRI's analytical services group, which, among other duties, develops and validates methods to ensure the purity, identity and strength of compounds being developed as potential therapeutic treatments. He joined AMRI in 1998 and has expanded the department's expertise in various analytical chemistry disciplines such as chromatographic chro·mat·o·graph n. An instrument that produces a chromatogram. tr.v. chro·mat·o·graphed, chro·mat·o·graph·ing, chro·mat·o·graphs To separate and analyze by chromatography. method development, chromatographic purification, and physical characterization of pharmaceutical compounds. Dr. Salerno was promoted to assistant director, analytical chemistry in 2000 and assumed oversight of analytical chemistry activities within all of AMRI's divisions. Earlier, Dr. Salerno managed a team of chemists at Oneida Research Services. His team completed multi-year studies that contributed to the approval of two new asthma products. Dr. Salerno received his Ph.D. in chemistry from the University of Buffalo. Jayachandra P. Reddy, Ph.D. has been promoted to director, process research and development at the Syracuse Research Center. As part of the Center's leadership team, Dr. Reddy works closely with AMRI Senior Director Gregory Reid to oversee customer relationships, recruit employees and manage scientific projects. Dr. Reddy joined AMRI from American Advanced Organics (AAO) in 2000. Before joining AAO in 1998, Dr. Reddy worked as a research scientist for four years at Bristol-Myers Squibb, where he was instrumental in the research and development of improved processes for several drug candidates. He received his Ph.D. in chemistry from the University of Kansas The University of Kansas (often referred to as KU or just Kansas) is an institution of higher learning in Lawrence, Kansas. The main campus resides atop Mount Oread. and conducted postdoctoral studies at Indiana University Indiana University, main campus at Bloomington; state supported; coeducational; chartered 1820 as a seminary, opened 1824. It became a college in 1828 and a university in 1838. The medical center (run jointly with Purdue Univ. . David A. Hunt, Ph.D. was promoted to assistant director, chemical development. Dr. Hunt joined AMRI in 2001, bringing 22 years of industry experience to the company. Prior to joining AMRI, Dr. Hunt was a senior group leader at Catalytica Pharmaceuticals and worked for ten years in the agricultural research division of American Cyanamid American Cyanamid was a large, diversified, American chemical manufacturer. Lederle Laboratories, maker of Centrum and Stresstabs vitamins, was Cyanamid's pharmaceutical division. Davis & Geck was the company's medical device division. Company. Dr. Hunt's industry experience also includes positions at Union Carbide's Agricultural Research Division, Becton Dickinson BD (NYSE: BDX), is a medical technology company that manufactures and sells medical devices, instrument systems and reagents. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs 27,000 people in nearly 50 countries. Research Center, PPG Industries PPG Industries (NYSE: PPG) was founded in 1883 as the Pittsburgh Plate Glass Company. PPG is an American manufacturer of glass and chemical products, including automotive safety glass. , and Salsbury Laboratories. Dr. Hunt has led or served on project teams responsible for the discovery or development of three commercial products. He received a Ph.D. in organic chemistry from Duke University. Paul F. Vogt, Ph.D. was promoted to section head, chemical development. Dr. Vogt joined Albany Molecular Research in 1997 as a senior research chemist. During his tenure at AMRI, he has contributed significantly to the company's growth. He has risen through the ranks, accumulating increased project management and supervisory responsibilities within the chemical development department. In his new position, Dr. Vogt will lead various project teams associated with process research and scale-up activities and manage scientific efforts and resources. Dr. Vogt received a Ph.D. in chemistry from the University of Notre Dame Notre Dame IPA: [nɔtʁ dam] is French for Our Lady, referring to the Virgin Mary. In the United States of America, Notre Dame . In addition to announcing the above-named management promotions, Dr. D'Ambra acknowledged a number of other individuals who have been promoted, including the following individuals in Albany and Rensselaer, New York Rensselaer is a city in Rensselaer County, New York, U.S., located on the Hudson River, directly opposite Albany. As of the 2000 census, the city population was 7,761; in 1920, it was 10,832. : Analytical Chemistry - Deborah A. Renner to research scientist III - Daniel E. Emrich, Ph.D. to senior research scientist - Silvina Garcia Rubio, Ph.D. to senior research scientist I - Sreenivasulu Guntha, Ph.D. to senior research scientist I Chemical Development - Deborah A. Renner to research scientist III - Daniel E. Emrich, Ph.D. to senior research scientist - Silvina Garcia Rubio, Ph.D. to senior research scientist I - Sreenivasulu Guntha, Ph.D. to senior research scientist I Combinatorial Chemistry Combinatorial chemistry involves the rapid synthesis or the computer simulation of a large number of different but structurally related molecules. Introduction Synthesis of molecules in a combinatorial fashion can quickly lead to large numbers of molecules. - Deborah A. Renner to research scientist III - Daniel E. Emrich, Ph.D. to senior research scientist - Silvina Garcia Rubio, Ph.D. to senior research scientist I - Sreenivasulu Guntha, Ph.D. to senior research scientist I Communications - Melanie J. Goldstein to web developer Human Resources - Kristina M. Sandberg to human resources administrator Medicinal Chemistry - Deborah A. Renner to research scientist III - Daniel E. Emrich, Ph.D. to senior research scientist - Silvina Garcia Rubio, Ph.D. to senior research scientist I - Sreenivasulu Guntha, Ph.D. to senior research scientist I Promotions at the company's Biocatalysis Research Division in Mount Prospect, Illinois Mount Prospect, part of Elk Grove Township and Wheeling Township, is a village in Cook County, Illinois about 22 miles northwest of downtown Chicago. Mount Prospect was incorporated as a village in 1917. As of the 2000 census, the village had a total population of 56,265. include the following: - Deborah A. Renner to research scientist III - Daniel E. Emrich, Ph.D. to senior research scientist - Silvina Garcia Rubio, Ph.D. to senior research scientist I - Sreenivasulu Guntha, Ph.D. to senior research scientist I Promotions at the company's Bothell Research Center in Bothell, Washington include the following: - Deborah A. Renner to research scientist III - Daniel E. Emrich, Ph.D. to senior research scientist - Silvina Garcia Rubio, Ph.D. to senior research scientist I - Sreenivasulu Guntha, Ph.D. to senior research scientist I Promotions at the company's Syracuse Research Center in Syracuse, New York
Syracuse (IPA: include the following: - Deborah A. Renner to research scientist III - Daniel E. Emrich, Ph.D. to senior research scientist - Silvina Garcia Rubio, Ph.D. to senior research scientist I - Sreenivasulu Guntha, Ph.D. to senior research scientist I "Today we are proud to announce the promotions of some of AMRI's finest employees. These important career milestones recognize each employee's growth and accomplishments, as well as their dedication to AMRI, its mission and its relationship with customers," said Chairman and Chief Executive Officer Thomas E. D'Ambra, Ph.D. "I would like to congratulate all of these employees for their contributions and commitment. I am privileged to represent and work with these talented individuals, each of whom has contributed to the company's success. I take great joy in seeing each of them grow personally and professionally. It is an honor to be able to recognize their efforts." Albany Molecular Research, Inc. is a chemistry-based drug discovery and development company, focusing on applications for new small molecule prescription drugs. The company conducts R&D projects and collaborates with many leading pharmaceutical, biotechnology and genomics companies, and is developing new chemistry technology for potential prescription drug applications. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion